1H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome.

Bibliographic Details
Title: 1H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome.
Authors: Gupta, Pooja Kri1 (AUTHOR), Barak, Sharon2 (AUTHOR), Feuermann, Yonatan1 (AUTHOR), Goobes, Gil2 (AUTHOR), Kaphzan, Hanoch1 (AUTHOR) hkaphzan@univ.haifa.ac.il
Source: Molecular Autism. 7/24/2024, Vol. 15 Issue 1, p1-14. 14p.
Subject Terms: *ANGELMAN syndrome, *PROTON magnetic resonance, *METABOLOMICS, *LABORATORY mice, *METABOLOMIC fingerprinting
Abstract: Background: Angelman syndrome (AS) is a rare neurodevelopmental genetic disorder caused by the loss of function of the ubiquitin ligase E3A (UBE3A) gene, affecting approximately 1:15,000 live births. We have recently shown that mitochondrial function in AS is altered during mid to late embryonic brain development leading to increased oxidative stress and enhanced apoptosis of neural precursor cells. However, the overall alterations of metabolic processes are still unknown. Hence, as a follow-up, we aim to investigate the metabolic profiles of wild-type (WT) and AS littermates and to identify which metabolic processes are aberrant in the brain of AS model mice during embryonic development. Methods: We collected brain tissue samples from mice embryos at E16.5 and performed metabolomic analyses using proton nuclear magnetic resonance (1H-NMR) spectroscopy. Multivariate and Univariate analyses were performed to determine the significantly altered metabolites in AS mice. Pathways associated with the altered metabolites were identified using metabolite set enrichment analysis. Results: Our analysis showed that overall, the metabolomic fingerprint of AS embryonic brains differed from those of their WT littermates. Moreover, we revealed a significant elevation of distinct metabolites, such as acetate, lactate, and succinate in the AS samples compared to the WT samples. The elevated metabolites were significantly associated with the pyruvate metabolism and glycolytic pathways. Limitations: Only 14 metabolites were successfully identified and investigated in the present study. The effect of unidentified metabolites and their unresolved peaks was not determined. Additionally, we conducted the metabolomic study on whole brain tissue samples. Employing high-resolution NMR studies on different brain regions could further expand our knowledge regarding metabolic alterations in the AS brain. Furthermore, increasing the sample size could reveal the involvement of more significantly altered metabolites in the pathophysiology of the AS brain. Conclusions: Ube3a loss of function alters bioenergy-related metabolism in the AS brain during embryonic development. Furthermore, these neurochemical changes could be linked to the mitochondrial reactive oxygen species and oxidative stress that occurs during the AS embryonic development. [ABSTRACT FROM AUTHOR]
Copyright of Molecular Autism is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:a9h&genre=article&issn=20402392&ISBN=&volume=15&issue=1&date=20240724&spage=1&pages=1-14&title=Molecular Autism&atitle=1H-NMR-based%20metabolomics%20reveals%20metabolic%20alterations%20in%20early%20development%20of%20a%20mouse%20model%20of%20Angelman%20syndrome.&aulast=Gupta%2C%20Pooja%20Kri&id=DOI:10.1186/s13229-024-00608-2
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: a9h
DbLabel: Academic Search Complete
An: 178622166
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: <superscript>1</superscript>H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Gupta%2C+Pooja+Kri%22">Gupta, Pooja Kri</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barak%2C+Sharon%22">Barak, Sharon</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Feuermann%2C+Yonatan%22">Feuermann, Yonatan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goobes%2C+Gil%22">Goobes, Gil</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kaphzan%2C+Hanoch%22">Kaphzan, Hanoch</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> hkaphzan@univ.haifa.ac.il</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Molecular+Autism%22">Molecular Autism</searchLink>. 7/24/2024, Vol. 15 Issue 1, p1-14. 14p.
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: *<searchLink fieldCode="DE" term="%22ANGELMAN+syndrome%22">ANGELMAN syndrome</searchLink><br />*<searchLink fieldCode="DE" term="%22PROTON+magnetic+resonance%22">PROTON magnetic resonance</searchLink><br />*<searchLink fieldCode="DE" term="%22METABOLOMICS%22">METABOLOMICS</searchLink><br />*<searchLink fieldCode="DE" term="%22LABORATORY+mice%22">LABORATORY mice</searchLink><br />*<searchLink fieldCode="DE" term="%22METABOLOMIC+fingerprinting%22">METABOLOMIC fingerprinting</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: Angelman syndrome (AS) is a rare neurodevelopmental genetic disorder caused by the loss of function of the ubiquitin ligase E3A (UBE3A) gene, affecting approximately 1:15,000 live births. We have recently shown that mitochondrial function in AS is altered during mid to late embryonic brain development leading to increased oxidative stress and enhanced apoptosis of neural precursor cells. However, the overall alterations of metabolic processes are still unknown. Hence, as a follow-up, we aim to investigate the metabolic profiles of wild-type (WT) and AS littermates and to identify which metabolic processes are aberrant in the brain of AS model mice during embryonic development. Methods: We collected brain tissue samples from mice embryos at E16.5 and performed metabolomic analyses using proton nuclear magnetic resonance (1H-NMR) spectroscopy. Multivariate and Univariate analyses were performed to determine the significantly altered metabolites in AS mice. Pathways associated with the altered metabolites were identified using metabolite set enrichment analysis. Results: Our analysis showed that overall, the metabolomic fingerprint of AS embryonic brains differed from those of their WT littermates. Moreover, we revealed a significant elevation of distinct metabolites, such as acetate, lactate, and succinate in the AS samples compared to the WT samples. The elevated metabolites were significantly associated with the pyruvate metabolism and glycolytic pathways. Limitations: Only 14 metabolites were successfully identified and investigated in the present study. The effect of unidentified metabolites and their unresolved peaks was not determined. Additionally, we conducted the metabolomic study on whole brain tissue samples. Employing high-resolution NMR studies on different brain regions could further expand our knowledge regarding metabolic alterations in the AS brain. Furthermore, increasing the sample size could reveal the involvement of more significantly altered metabolites in the pathophysiology of the AS brain. Conclusions: Ube3a loss of function alters bioenergy-related metabolism in the AS brain during embryonic development. Furthermore, these neurochemical changes could be linked to the mitochondrial reactive oxygen species and oxidative stress that occurs during the AS embryonic development. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Molecular Autism is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=a9h&AN=178622166
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13229-024-00608-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 14
        StartPage: 1
    Subjects:
      – SubjectFull: ANGELMAN syndrome
        Type: general
      – SubjectFull: PROTON magnetic resonance
        Type: general
      – SubjectFull: METABOLOMICS
        Type: general
      – SubjectFull: LABORATORY mice
        Type: general
      – SubjectFull: METABOLOMIC fingerprinting
        Type: general
    Titles:
      – TitleFull: 1H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gupta, Pooja Kri
      – PersonEntity:
          Name:
            NameFull: Barak, Sharon
      – PersonEntity:
          Name:
            NameFull: Feuermann, Yonatan
      – PersonEntity:
          Name:
            NameFull: Goobes, Gil
      – PersonEntity:
          Name:
            NameFull: Kaphzan, Hanoch
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 07
              Text: 7/24/2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 20402392
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular Autism
              Type: main
ResultId 1